Skip to content

Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research

Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01049555
Acronym
09-PP-06
Enrollment
42
Registered
2010-01-14
Start date
2011-09-30
Completion date
2012-12-31
Last updated
2015-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Keywords

alzheimer, apathy, actigraphy

Brief summary

Neuropsychiatric symptoms form part of the clinical picture of Alzheimer's disease (AD) and other dementias. Irrespective of the severity of the disease, the most frequently encountered symptom is apathy. Apathy is increasingly diagnosed in patients with neurological and psychiatric conditions. Apathy is a disorder of motivation, defined as the direction, intensity and persistence of goal-directed behaviour. Most of the current descriptions acknowledge this point and consider apathy in terms of a lack of goal-directed behaviour, cognition or emotion. The classical neuropsychiatric symptom assessments are subjective structured interview-based, using input from the caregiver and/or the patient. New technologies are likely to provide us with a more objective measure. An example is ambulatory actigraphy, consisting of a piezoelectric accelerometer designed to record arm movement in three dimensions. The aim of the present study is to assess using actigraphy and video recording signal, AD patients with (n = 15) and without (n = 15) apathy and control subjects (n = 5) during an activity of daily living scenario .

Interventions

OTHERActigraphy and video recording signal

Actigraphy and video recording signal during 1 hour

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* male or female, \> 65 years ; * Alzheimer's disease according to the NINCDS-ADRDA criteria (McKhann,Drachman et al. 1984) ; * Mini Mental Test Examination (MMSE) \> 20 ; * no motor anomaly according to UPDRS III (tremblements, rigidité musculaire) ; * no depression criteria according to DSM IV-R criteria ; * patient with a cholinergic treatment at dose stable since 3 months ; * patient with social insurance ; * signature of informed consent.

Exclusion criteria

* neuropsychologics assessment impossible due to sensorial and disrupt ; * prescription of psychotrop treatment (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week previous actigraphy recording.

Design outcomes

Primary

MeasureTime frame
assessment of motricityone time point - at the only visit of protocol

Secondary

MeasureTime frame
video recordingone time point - at the only visit of the protocol

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026